Related Experiment Video
Updated: May 27, 2025

07:00
Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
6.1K
Complement activation at the interface between adipocytes and cancer cells drives tumor progression
Andres Valdivia1, Ana Maria Isac1, Horacio Cardenas1
1Department of Obstetrics and Gynecology.
JCI Insight
|February 18, 2025
Summary
Adipocytes in the omentum promote ovarian cancer (OC) metastasis by transferring lipids to cancer cells. This activates the integrated stress response (ISR), increasing complement C3/C5 proteins and driving tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis
Background:
- The omentum is a frequent site for ovarian cancer (OC) metastasis.
- Adipocyte-cancer cell interactions promote an invasive and prometastatic phenotype in OC.
Purpose of the Study:
- To investigate the molecular mechanisms of cancer cell-adipocyte crosstalk in OC metastasis.
- To identify key pathways and molecules involved in adipocyte-driven OC progression.
Main Methods:
- Direct coculture of immortalized human visceral nondiabetic pre-adipocytes (VNPADs) with OC cells.
- RNA sequencing to analyze transcriptomic changes in cocultured OC cells.
- In vitro functional assays and in vivo tumor progression models.
- Analysis of complement C3 and C5 protein expression and function.
Main Results:
- Cocultured OC cells exhibited increased proliferation, invasiveness, and cisplatin resistance compared to monocultured cells.
- Significant transcriptomic changes were observed, with enriched pathways including PI3K/AKT and complement activation.
- Lipid transfer from adipocytes induced upregulation of complement C3 and C5 proteins in OC cells.
- Inhibition of C3/C5 reversed invasiveness, and C3 knockdown reduced tumor progression in vivo.
- Increased C3 expression was found in omental implants and OC ascites from high-BMI patients.
- C3 upregulation involved the ATF4-mediated integrated stress response (ISR).
Conclusions:
- Adipocyte-cancer cell interactions promote OC invasiveness and tumorigenesis.
- Lipid transfer, ISR activation, and complement C3/C5 upregulation are key mechanisms.
- Targeting these pathways may offer therapeutic strategies for OC metastasis.
Related Concept Videos
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Selectins
3.2K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K

